Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exploring The Therapeutic Benefits Of Oral Protein Supplementation In Malnourished Dialysis Patients
Brief Summary: The dialysis population has a strikingly high incidence of mortality. The life expectancy of chronic dialysis patients is 20 years less than that of the general population. Approximately 50% of individuals with end stage renal disease (ESRD) die from a cardiovascular (CV) cause with mortality being 15 to 30 times higher than the age-adjusted CV mortality in the general population. There is also a steady increase of patients with diabetes and the older age groups coming into dialysis. The treatment of patients with ESRD aims at prolonging life, achieving good nutritional status and promoting the best possible functioning and quality of life (QOL). Several factors that are beyond adequacy of dialysis predict high mortality in ESRD patients. Associated co-morbidities and malnutrition factors are independently associated and the combined presence of both malnutrition and co-morbidities manifest the worst survival.Therefore this study investigates the efficacy of protein supplementation in improving health status and quality of life among peritoneal dialysis (PD) patients. This research will also generate basic data about significant health markers critical to the health status of PD patients.


Options:
A: Arm Label: Standard Hemodialysis; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Hemodialysis with Nutrition Supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nepro | Arm Label: Nutrition Supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nepro | Intervention Type: DIETARY_SUPPLEMENT; Name: Nepro; Assigned to Arm(s): Hemodialysis with Nutrition Supplement, Nutrition Supplement
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nepro nutritional supplement | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Nepro nutritional supplement; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: pentoxiphylline, Dietary Supplement: Nepro, Dietary Supplement: anti-inflammatory module (similar to Oxepa) | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Nepro, Dietary Supplement: anti-inflammatory module (similar to Oxepa), Drug: Placebo pill imitating pentoxiphylline | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: pentoxiphylline, Dietary Supplement: Placebo to imitate Nepro, Dietary Supplement: Placebo to imitate anti-inflammatory module (similar to Oxepa) | Arm Label: D; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo pill imitating pentoxiphylline, Dietary Supplement: Placebo to imitate Nepro, Dietary Supplement: Placebo to imitate anti-inflammatory module (similar to Oxepa) | Intervention Type: DRUG; Name: pentoxiphylline; Assigned to Arm(s): A, C | Intervention Type: DIETARY_SUPPLEMENT; Name: Nepro; Assigned to Arm(s): A, B | Intervention Type: DIETARY_SUPPLEMENT; Name: anti-inflammatory module (similar to Oxepa); Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Placebo pill imitating pentoxiphylline; Assigned to Arm(s): B, D | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo to imitate Nepro; Assigned to Arm(s): C, D | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo to imitate anti-inflammatory module (similar to Oxepa); Assigned to Arm(s): C, D
D: Arm Label: Ceprolac; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Ceprolac | Arm Label: Dietary counseling (DC); Type: PLACEBO_COMPARATOR; Interventions: Other: Dietary counseling (DC) | Intervention Type: DIETARY_SUPPLEMENT; Name: Ceprolac; Assigned to Arm(s): Ceprolac | Intervention Type: OTHER; Name: Dietary counseling (DC); Assigned to Arm(s): Dietary counseling (DC)

Answer: D